Enjoy complimentary customisation on priority with our Enterprise License!
The X-Ray crystallography market size is estimated to grow by USD 678 million at a CAGR of 12.76% between 2023 and 2028. The market is experiencing significant growth due to the increasing investment in drug discovery and development. Outsourcing of drug discovery processes to specialized laboratories is also driving market expansion. However, the lack of trained laboratory professionals poses a challenge to market growth. This trend is being addressed through collaborations between academia and industry, as well as the development of training programs. Additionally, advancements in technology, such as automation and high-throughput methods, are improving efficiency and reducing costs. These factors, along with the growing importance of structural biology in research and development, are expected to continue fueling market growth in the coming years.
To learn more about this report, Request Free Sample
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Agilent Technologies Inc., Anton Paar GmbH, ARINAX SAS, Bruker Corp., Calibre Scientific Inc., Charles River Laboratories International Inc., Hitachi High Tech Corp., HUBER Diffraktionstechnik GmbH and Co. KG, Intertek Group Plc, MiTeGen LLC, Nippon Kayaku Co. Ltd., Olympus Corp., Perkin Elmer Inc., Rigaku Corp., Shimadzu Corp., Spectris Plc, Tecan Trading AG, Thermo Fisher Scientific Inc., and WuXi AppTec Co. Ltd.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The Pharmaceutical segment is estimated to witness significant growth during the forecast period. X-Ray Crystallography is a crucial technique in the field of material science and physical science, used to determine the atomic and molecular structure of various substances, including biological macromolecules such as proteins, enzymes, viruses, protein-nucleic acid complexes, and protein-ligand interactions. This is achieved by directing an X-ray beam at a crystal and analyzing the resulting diffraction pattern.
Get a glance at the market contribution of various segments Download PDF Sample
The Pharmaceutical segment was the largest segment and was valued at USD 207.80 million in 2018. The wavelengths of the X-rays enable the determination of interatomic distances, providing valuable insights into the crystal structures. Applications of X-ray crystallography extend beyond the realm of biology, with uses in various industries such as electronics, cosmetics, and archaeology. In the pharmaceutical industry, it plays a significant role in drug discovery, particularly in the analysis of membrane proteins. The increasing investments in pharmaceutical R&D drive the growth of the X-ray crystallography market. Europe, with countries like Switzerland, Belgium, Slovenia, and Denmark leading in pharmaceutical R&D spending, is a major contributor to the market. The market for X-ray crystallography is diverse, with key players including technology vendors, research laboratories, pharma companies, CROs, and exhibitions and conferences. Key components of the technology include diffractometers, X-Ray Optics, crystals, cryoprotectants, and X-Ray sources. The market is further propelled by advancements in X-Ray Optics, the development of more efficient diffractometers, and the increasing use of synchrotron radiation sources. In summary, X-Ray Crystallography is a vital technique in the analysis of crystal structures, with applications in various industries, particularly in drug discovery and structural biology. The increasing investments in R&D, especially in the pharmaceutical sector, drive the growth of the X-Ray Crystallography market. The market is diverse, with key players including technology vendors, research laboratories, pharma companies, CROs, and exhibitions and conferences. Components of the technology include diffractometers, X-Ray Optics, crystals, cryoprotectants, and X-Ray sources.
For more insights about the market share of various regions Download PDF Sample
North America is estimated to contribute 33% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers will shape the market during the forecast period.
X-ray crystallography is a revolutionary technique in the realm of physical science, used to determine the three-dimensional structures of crystals, including biological macromolecules such as proteins, enzymes, viruses, protein-nucleic acid complexes, and protein-ligand interactions. This technique employs an X-ray beam, which interacts with the crystals, producing a diffraction pattern. The wavelengths of the X-rays and the interatomic distances within the crystals enable the calculation of their structures. Applications of X-ray crystallography span various industries, including biotechnology, pharmacy, cosmetic industries, hospitals, research laboratories, pharma companies, CROs, technology vendors, and exhibitions and conferences. Crystals of interest include DNA, bones, teeth, cosmetics, electronic chips, jewels, artefacts, natural atomic structures, and organic compounds. X-ray optics, diffractometers, cryoprotectants, and material science chemicals are essential tools in this field. X-ray crystallography significantly advances our understanding of the atomic and molecular structures, contributing to advancements in medicine, electronics, and materials science.
X-ray crystallography is a powerful analytical technique used to determine the three-dimensional structures of crystals. The process involves passing an X-ray beam through a crystal, which results in a diffraction pattern. Analyzing the diffraction pattern allows for the determination of interatomic distances and the overall crystal structure. This technique has been instrumental in the study of various fields, including protein structure analysis of biological macromolecules such as enzymes, viruses, protein-nucleic acid complexes, and protein-ligand interactions. X-ray crystallography plays a crucial role in drug discoveries for chronic diseases in healthcare, as well as in mineralogy & metallurgy and the study of bones. The technique uses X-rays with specific wavelengths to illuminate the crystal, revealing its inner structure. Electrons also play a role in the process, as they scatter the X-rays and create the diffraction pattern. In addition to its applications in healthcare services, X-ray crystallography is also used in optics. Our researchers analyzed the market research and growth data with 2023 as the base year, along with the key market growth analysis, trends, and challenges. A holistic analysis of drivers, trends, and challenges will help companies refine their marketing strategies to gain a competitive advantage.
Growing investment in drug discovery is notably driving market growth. X-ray crystallography, a technique based on X-ray diffraction technique, plays a pivotal role in advancing healthcare and scientific research, particularly in the pharmaceutical and life science & biotechnology sectors. With the global burden of chronic diseases on the rise, the demand for new and innovative drugs is surging. Pharmaceutical and biopharmaceutical companies are investing heavily in research and development (R&D), allocating approximately 65% of their revenue towards discovery and early-stage product development.
Furthermore, this investment is driven by the need to address therapeutic areas such as immunology, cancer, and infectious diseases. In addition, X-ray crystallography is also extensively used in mineralogy & metallurgy, optics, and other industries for material research and analysis. By providing insights into the molecular structures of substances, X-ray crystallography aids in the discovery and development of new materials, improving the overall efficiency and effectiveness of various industries. Thus, such factors are driving the growth of the market during the forecast period.
Outsourcing of drug discovery process is the key trend in the market. X-ray crystallography, a technique based on X-ray diffractions, plays a pivotal role in various industries including healthcare, mineralogy & metallurgy, and life science & biotechnology. In healthcare, particularly in the pharmaceutical sector, this technology is extensively utilized for drug discoveries. Due to the high capital requirements for establishing in-house research facilities, many companies have opted for outsourcing their drug discovery processes to Contract Research Organizations (CROs).
Furthermore, this approach allows these companies to focus on manufacturing, marketing, and innovation, while CROs handle the research and development. The application of X-ray crystallography in this context enables the identification of the molecular structures of electrons, aiding in the development of potential treatments for chronic diseases. This outsourcing trend is expected to continue, as it offers cost savings and allows pharmaceutical companies to allocate resources towards market promotion and other strategic initiatives. Thus, such trends will shape the growth of the market during the forecast period.
Lack of trained laboratory professionals is the major challenge that affects the growth of the market. X-ray crystallography, a technique that utilizes X-ray diffractions to determine the molecular structures of substances, plays a pivotal role in various sectors, including healthcare, optics, mineralogy & metallurgy, and pharmaceutical, life science & biotechnology. This process demands meticulous handling of reagents and equipment, as well as an expert interpretation of results. With the increasing focus on drug discoveries for chronic diseases, the need for molecular research experiments is escalating.
However, the shortage of skilled professionals in this field is posing a significant challenge to the industry. According to reports, over 60% of jobs in the US pharmaceutical sector are projected to be vacant by 2025 due to insufficient education policies and intensifying competition from other countries. This talent crunch is impeding market growth and underscores the importance of attracting and retaining qualified experts in X-ray crystallography. Hence, the above factors will impede the growth of the market during the forecast period
The market forecast report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market forecasting and growth strategies.
Customer Landscape
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million " for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
X-Ray Diffractometer (XRD) Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, Japan, China - Size and Forecast
Scientific Instrument Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, China, Germany, UK, India - Size and Forecast
Proteomics MarketAnalysis North America, Europe, Asia, Rest of World (ROW) - US, UK, Germany, China, Japan - Size and Forecast
X-Ray Crystallography is a revolutionary technique used to determine the three-dimensional structures of crystals. This method employs an X-ray beam that interacts with the crystal, producing a diffraction pattern. The wavelengths of the X-rays and the interatomic distances within the crystal are crucial in deciphering the diffraction pattern, thereby revealing the protein structure, enzymes, viruses, protein-nucleic acid complexes, protein-ligand interactions, DNA, bones, teeth, cosmetics, electronic chips, jewels, artifacts, natural atomic structures, and organic compounds.
Furthermore, X-Ray Crystallography finds extensive applications in material science, chemicals, physical science, atomic science, biotechnology, pharmacy, cosmetic industries, hospitals, research laboratories, pharma companies, CROs, technology vendors, and various other sectors. The technique is instrumental in understanding the intricacies of crystal structures and their behavior under different conditions. Exhibitions, conferences, and other scientific events serve as platforms for sharing knowledge and advancements in X-Ray Crystallography. Crystals, X-Ray Optics, diffractometers, cryoprotectants, and related technologies play a pivotal role in the successful implementation of this technique. The market for X-Ray Crystallography is thriving, with significant investments from various industries and continuous research and development efforts.
Market Scope |
|
Report Coverage |
Details |
Page number |
147 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 12.76% |
Market growth 2024-2028 |
USD 678 million |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
11.86 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 33% |
Key countries |
US, Germany, China, UK, and Japan |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
Agilent Technologies Inc., Anton Paar GmbH, ARINAX SAS, Bruker Corp., Calibre Scientific Inc., Charles River Laboratories International Inc., Hitachi High Tech Corp., HUBER Diffraktionstechnik GmbH and Co. KG, Intertek Group Plc, MiTeGen LLC, Nippon Kayaku Co. Ltd., Olympus Corp., Perkin Elmer Inc., Rigaku Corp., Shimadzu Corp., Spectris Plc, Tecan Trading AG, Thermo Fisher Scientific Inc., and WuXi AppTec Co. Ltd. |
Market dynamics |
Parent market analysis, Market Forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for market forecast period. |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.